Alpha-lipoic acid , an antioxidant with specific evidence in diabetic neuropathy, may complement peptide protocols by reducing oxidative stress in peripheral nerves
Por encima de 3 g/da, los beneficios adicionales son marginales y el riesgo de efectos digestivos aumenta
J Diabetes Sci Technol 8:132141 Ratziu V, Harrison SA, Francque S et al (2016) Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
Long-term safety is unknown for both
Growth hormone-releasing activity of hexarelin in research subjects
Data were generated and/or analyzed by the Proteomics Resource Center (RRID: SCR_017797), Electron Microscopy Resource Center, Bioinformatics Resource Center, Fisher Drug Discovery Resource Center, and the Flow Cytometry Resource Center at The Rockefeller University